169 related articles for article (PubMed ID: 10836400)
1. Mycophenolate mofetil in the prevention of rejection after kidney transplantation.
Kiehl MG
Transplantation; 2000 Apr; 69(8):1753-4. PubMed ID: 10836400
[No Abstract] [Full Text] [Related]
2. Mycophenolate mofetil for prevention of acute rejection.
Winearls CG
Lancet; 1995 Jul; 346(8969):253-4. PubMed ID: 7616828
[No Abstract] [Full Text] [Related]
3. Mycophenolate Mofetil Study.
Baltzan M; Shoker A; Baltzan R
Transplantation; 1997 Jan; 63(1):173-4. PubMed ID: 9000687
[No Abstract] [Full Text] [Related]
4. Mycophenolate mofetil for prevention of acute rejection.
Moore R; Griffin P; Darby C; Jurewicz A; Lord R
Lancet; 1995 Jul; 346(8969):253. PubMed ID: 7616827
[No Abstract] [Full Text] [Related]
5. [Mycophenolate mofetil: a new approach by immunosuppressive treatment].
Thervet E
Pathol Biol (Paris); 2001 Feb; 49(1):9-11. PubMed ID: 11265229
[No Abstract] [Full Text] [Related]
6. Is mycophenolate mofetil better than azathioprine in organ transplantation?
Ruggenenti P; Remuzzi G
Transplantation; 2006 Nov; 82(9):1242-3. PubMed ID: 17102781
[No Abstract] [Full Text] [Related]
7. Mycophenolate mofetil for the transplanted kidney?
Drug Ther Bull; 1997 May; 35(5):38-40. PubMed ID: 9282420
[TBL] [Abstract][Full Text] [Related]
8. Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection.
Nicholls AJ
Clin Biochem; 1998 Jul; 31(5):329-33. PubMed ID: 9721430
[No Abstract] [Full Text] [Related]
9. Mofetil mycophenolate in renal transplantation.
Pretagostini R; Rossi M; Berloco P; Colonnello M; Bruzzone P; Peritore D; Lonardo MT; Cortesini R
Transplant Proc; 2001; 33(1-2):1082-3. PubMed ID: 11267200
[No Abstract] [Full Text] [Related]
10. The Tricontinental Mycophenolate Mofetil Trial.
Browne BJ
Transplantation; 1996 Dec; 62(11):1697. PubMed ID: 8970635
[No Abstract] [Full Text] [Related]
11. The evolving role of mycophenolate mofetil in renal transplantation.
Warrens AN
QJM; 2000 Jan; 93(1):15-20. PubMed ID: 10623777
[No Abstract] [Full Text] [Related]
12. Simultaneous pancreas/kidney transplantation: comparison of mycophenolate mofetil versus azathioprine.
Elkhammas EA; Yilmaz S; Henry ML; Yenchar J; Bumgardner GL; Pelletier RP; Ferguson RM
Transplant Proc; 1998 Mar; 30(2):512. PubMed ID: 9532152
[No Abstract] [Full Text] [Related]
13. Mycophenolate mofetil versus azathioprine in organ transplantation.
Cravedi P; Perna A; Ruggenenti P; Remuzzi G
Am J Transplant; 2009 Dec; 9(12):2856-7. PubMed ID: 19845579
[No Abstract] [Full Text] [Related]
14. Mycophenolate mofetil, tacrolimus, Neoral: from clinical trials to the clinic.
Pirsch JD
Transplant Proc; 1998 Aug; 30(5):2223-5. PubMed ID: 9723448
[No Abstract] [Full Text] [Related]
15. Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection.
Miladipour AH; Ghods AJ; Nejadgashti H
Transplant Proc; 2002 Sep; 34(6):2089-90. PubMed ID: 12270325
[No Abstract] [Full Text] [Related]
16. Long-term benefit of mycophenolate mofetil in renal transplantation.
Lang P; Pardon A; Audard V
Transplantation; 2005 Feb; 79(3 Suppl):S47-8. PubMed ID: 15699751
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year. The U.S. Mycophenolate Mofetil Study Group.
Transplant Proc; 1997; 29(1-2):348-9. PubMed ID: 9123033
[No Abstract] [Full Text] [Related]
18. Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction.
Senn B; Rochat P; Schwarzkopf AK; Weinreich T; Binswanger U
Transplant Proc; 1998 Dec; 30(8):4075-6. PubMed ID: 9865301
[No Abstract] [Full Text] [Related]
19. Prospective study of mycophenolate mofetil for the prevention of acute rejection in living donor renal allograft recipients.
Park K; Kim SI; Moon JI; Kim YS; Kim MS
Transplant Proc; 1998 Nov; 30(7):3575. PubMed ID: 9838565
[No Abstract] [Full Text] [Related]
20. The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid.
Kuriata-Kordek M; Boratyńska M; Klinger M; Woźniak M; Urbaniak J; Szyber P; Patrzalek D; Tupka D
Transplant Proc; 2002 Nov; 34(7):2985-7. PubMed ID: 12431678
[No Abstract] [Full Text] [Related]
[Next] [New Search]
